查詢結果分析
相關文獻
- Comparison of Transrectal Ultrasound-guided Biopsy of the Prostate and Transurethral Resection of the Prostate for Detection of Prostate Cancer in Patients with Moderate Lower Urinary Tract Symptoms
- Detection of Prostatic Cancer Using Digital Rectal Examination, Prostate-Specific Antigen and Transrectal Ultrasonography
- Transurethral Prostatic Resection for Acute Urinary Retention in Patients with Prostate Cancer
- 攝護腺癌早期診斷指引:摘譯2014年美國泌尿科醫學會評論
- Elevated Prostate-specific Antigen in Pleural Effusion: A Case Report
- Flutamide-Induced Liver Injury: A Case Report
- 攝護腺癌之化學藥物治療
- 攝護腺癌的放射線治療及其護理
- Free-to-total Serum Prostate Specific Antigen Ratio in Chinese Men
- Tanagho's Procedure for Total Urinary Incontinence--A Case Report
頁籤選單縮合
| 題 名 | Comparison of Transrectal Ultrasound-guided Biopsy of the Prostate and Transurethral Resection of the Prostate for Detection of Prostate Cancer in Patients with Moderate Lower Urinary Tract Symptoms=對有中度下泌尿道症狀病人經直腸攝護腺切片及經尿道攝護腺切除偵測攝護腺癌的比較 |
|---|---|
| 作 者 | 陳修聖; 邱麗萍; 陳光國; | 書刊名 | Journal of the Chinese Medical Association |
| 卷 期 | 73:11 2010.11[民99.11] |
| 頁 次 | 頁568-572+CA101 |
| 分類號 | 416.275 |
| 關鍵詞 | 攝護腺癌; 攝護腺特異性抗原; 經直腸攝護腺超音波切片; 經尿道攝護腺切除; Prostate cancer; Prostate-specific antigen; Transrectal ultrasound biopsy; Transurethral resection of the prostate; |
| 語 文 | 英文(English) |
| 英文摘要 | Background: To compare transrectal ultrasound (TRUS)-guided biopsy of the prostate and transurethral resection of the prostate (TURP) for detection of prostate cancer (PCa) in patients with moderate lower urinary tract symptoms (LUTS) by retrospective chart review. Methods: Between January 2004 and December 2008, a total of 520 patients, aged 50.3–81.5 years, with moderate LUTS (International Prostate Symptom Score, 8–19), and elevation of prostate-specific antigen (≥ 4 ng/mL), or abnormal findings by digital rectal examination, were enrolled for evaluation. All the patients were recommended to receive TRUSguided biopsy of the prostate (TRUS biopsy group) or TURP (TURP group) due to the possibility of PCa, according to their choice after full explanation by the doctors. Results: There were 379 patients in the TRUS biopsy group and 141 in the TURP group. PCa was detected in 80 patients (21.1%) in the TRUS group and in 27 (19.1%) in the TURP group. Clinically localized PCa (T1–2N0M0) was found in 46 patients (57.5%) in the TRUS biopsy group and in 16 (59.3%) in the TURP group. Bone metastasis was noticed in 22 (27.5%) patients in the TRUS biopsy group and in 7 (25.9%) in the TURP group. The percentage of low-grade tumor was significantly higher in the TURP group than in the TRUS biopsy group (11.1% vs. 5%). Conclusion: TURP was not superior to TRUS-guided biopsy of the prostate for detection of PCa in patients with moderate LUTS and prostate-specific antigen ≥ 4 ng/mL. |
本系統中英文摘要資訊取自各篇刊載內容。